Skip to main content
SARS-CoV-2

What is SARS-CoV-2

SARS-CoV-2 is a virulent coronavirus, similar in structure to the SARS-CoV virus that was responsible for the 2002 SARS pandemic, that causes the infectious disease COVID-19. SARS-CoV-2 binds to the cell surface receptor Angiotensin-Converting-Enzyme-2 (ACE-2) to pass through the cell membrane and enter the host cell. The preliminary identification and characterization of the structure and mechanism of action of SARS-CoV-2 have enabled the development of early detection assays for the virus. However, further research is needed to develop more reliable detection tests and potentially develop anti-viral therapies. Through our brands, we offer an unparalleled selection of research tools for the study of SARS-CoV-2 and COVID-19.

Find Out if You Have COVID-19 From the Convenience of Your Home

Take advantage of our CLIA-certified, CAP-accredited laboratory to determine if you have COVID-19. We will send you an at-home sample collection kit from Exosome Diagnostics, a Bio-Techne brand. Collect a nasal swab sample and send it back to us. We will test your sample using our CLIA-validated RT-qPCR method, which detects SARS-CoV-2 with 100% specificity and 98% sensitivity. Results are received in 36 to 72 hours from time of sample receipt. Our test is ideal for busy professionals, travelers, and for those who can’t wait.

Bio-Techne offers individuals an COVID-19 detection test with an at-home sample collection kit.
R&D Systems antibodies for SARS-CoV-2 research and the development of COVID-19 diagnostic tools and therapeutics.

R&D Systems™ Antibodies for Coronavirus Research

R&D Systems, a Bio-Techne brand, offers a large selection of antibodies for SARS‑CoV‑2 and COVID‑19 research. Our antibodies are essential tools that have supported pivotal research on SARS‑CoV‑2 recognition and viral infection and are being used to develop assays for SARS‑CoV‑2 detection.

Explore the resources Novus Biologicals offers for COVID-19 research.

Tools for COVID-19 Research from Novus Biologicals

Novus Biologicals, a Bio-Techne brand, specializes in providing tools to support emerging areas of research, such as the COVID‑19 pandemic. Their selection of SARS‑CoV‑2 proteins and antibodies have been used to further the understanding of SARS‑CoV‑2 infection, including by the CDC for the immunohistochemistry detection of SARS‑CoV‑2.

coronavirus variants

R&D Systems™ Proteins for Coronavirus Research

R&D Systems, a Bio-Techne brand, offers a wide selection of recombinant proteins for SARS‑CoV‑2 research, including the U.K. and South African variant Spike proteins. All of our proteins are produced and purified in-house and are rigorously tested for bioactivity and lot-to-lot consistency.

Mechanism of SARS-CoV-2 viral cell entry

Tocris™ Small Molecules for COVID‑19 Research

Bio‑Techne, through the Tocris brand, provides a wide range of small molecules for exploring different stages of the SARS‑CoV‑2 viral lifecycle. The Tocris catalog offers products for targets involved in viral cell entry, including ACE2, TMPRSS2, and targets important in viral replication, such as Mpro, PLpro and RNA polymerase. The range includes FDA approved drugs, innovative new compounds, as well as fluorescent reagents.

Bio-Techne offers llamabodies, also called camelid antibodies and nanobodies, for SARS-CoV-2 research.

LlaMABody™-Camelid Antibodies for Coronavirus Research

Our SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody is produced using the VHH72 CoV-2 RBD Blocking/Neutralization clone that was published by Wrapp, D. et al. in Cell. Learn more about this camelid antibody and our LlaMABody product line on the R&D Systems website, a Bio-Techne brand. 

Additional Coronavirus Resources

Tools to Support New Coronavirus Research Brochure

Download our brochure to explore the tools from all the Bio-Techne brands that can support and further SARS-CoV-2 and COVID-19 research.

Inside the COVID-SeroIndex™ Assay Design and Performance Webinar

Watch this webinar to learn about the development of COVID-SeroIndex, a quantitative ELISA designed to measure SARS-CoV-2-IgG antibodies, through our partnership with Kantaro Biosciences – a Mount Sinai Venture.

Monitor SARS-CoV-2 and ACE-2 Interactions with Flow Cytometry Webinar

Watch this webinar to see how flow cytometry can be used to investigate ACE-2 expression, monitor the immune response to SARS-CoV-2 infection, and evaluate the effectiveness of antibodies and/or small molecules to block SARS-CoV-2 binding to ACE-2.

New Research Tools to Help the Fight Against SARS-CoV-2 Webinar

In this webinar, Bio-Techne scientists are joined by Joep Beumer, from the Hans Clevers lab at the Hubrecht Institute, to discuss different aspects of COVID-19 research including the use of intestinal organoids to model SARS-CoV-2 infection.

Next Generation of Analytical Tools for Vaccine Development Webinar

Watch this webinar to learn how scientists from leading pharmaceutical companies use Bio-Techne’s automated analytical technologies throughout the the vaccine development workflow.

Improved COVID-19 Research with Bio-Techne Automated Platforms Webinar

Watch this webinar to learn how the automated platforms from our ProteinSimple brand can be utilized for COVID-19 basic research and serological assay development.